US drug approvals
67 approvals with a product on the US market
- Clobetasol Propionate ANDA210638 · approved 20 Nov 2025
- Progesterone ANDA218391 · approved 19 Sep 2025
- Methylene Blue ANDA219363 · approved 30 Jul 2025
- Cetrorelix Acetate ANDA218061 · approved 3 Jun 2025
- Levothyroxine Sodium ANDA217495 · approved 29 Nov 2024
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.